Addiction drug maker will pay more than $102 million fine for stifling competition

2024-12-25 21:13:57 source:lotradecoin security category:News

The maker of an important addiction treatment medication has agreed to pay $102 million dollars to settle claims it stifled competition. Indivior makes Suboxone, which reduces drug cravings in people with opioid use disorder.

The Virginia-based Indivior introduced Suboxone in 2002 and then, according to state attorneys general, used "monopolistic" strategies to keep generic versions of the opioid-treatment medication off the market.

New York Attorney General Letitia James released a statement saying Indivior "selfishly maneuvered to keep less expensive versions of a life-saving drug out of the hands of millions of Americans" as the opioid crisis grew.

States sued the company in 2016. This settlement with 41 states and the District of Columbia ends that legal fight.

In a statement, Indivior admitted no wrongdoing and said this deal allows the company to focus on patient care.

"We take our role as a responsible steward of medications for addiction and rescue extremely seriously," said Indivior CEO Mark Crossley. "Resolving these legacy matters at the right value allows us to further this mission for patients."

Company officials said they expect to pay the $102.5 million from cash on hand later this month.

More:News

Recommend

Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Dropping Hints

There are spoilers ahead. You might want to solve today's puzzle before reading further! Dropping Hi

FBI investigates cybersecurity issue at MGM Resorts while casinos and hotels stay open across US

LAS VEGAS (AP) — Casino operator MGM Resorts International said Tuesday that resorts are open and an

The myth of the money spider and the power of belief credited for UK woman's lottery win

A woman in the United Kingdom will get £10,000 (US$12,465) per month for the next 30 years after she